Sernova Corp. (SVA.TO)

CAD 0.23

(0.0%)

Total Debt Summary of Sernova Corp.

  • Sernova Corp.'s latest annual total debt in 2023 was 136.12 Thousand CAD , down -50.68% from previous year.
  • Sernova Corp.'s latest quarterly total debt in 2024 Q1 was 634.63 Thousand CAD , up 366.22% from previous quarter.
  • Sernova Corp. reported annual total debt of 275.97 Thousand CAD in 2022, down -29.84% from previous year.
  • Sernova Corp. reported annual total debt of 393.35 Thousand CAD in 2021, down -44.02% from previous year.
  • Sernova Corp. reported quarterly total debt of 613.78 Thousand CAD for 2024 Q2, down -3.28% from previous quarter.
  • Sernova Corp. reported quarterly total debt of 592.23 Thousand CAD for 2024 Q3, down -3.51% from previous quarter.

Annual Total Debt Chart of Sernova Corp. (2023 - 1999)

Historical Annual Total Debt of Sernova Corp. (2023 - 1999)

Year Total Debt Total Debt Growth
2023 136.12 Thousand CAD -50.68%
2022 275.97 Thousand CAD -29.84%
2021 393.35 Thousand CAD -44.02%
2020 702.61 Thousand CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD -100.0%
2005 87.65 Thousand CAD -5.4%
2004 92.65 Thousand CAD 0.0%
2003 - CAD 0.0%
2002 - CAD 0.0%
2001 - CAD 0.0%
2000 - CAD 0.0%
1999 - CAD 0.0%

Peer Total Debt Comparison of Sernova Corp.

Name Total Debt Total Debt Difference
Appili Therapeutics Inc. 8.18 Million CAD 98.337%
Eupraxia Pharmaceuticals Inc. 13.78 Million CAD 99.012%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 6.64 Million CAD 97.952%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. - CAD -Infinity%
Oncolytics Biotech Inc. 423 Thousand CAD 67.82%